Form 10-Q · Quarterly report
Monster Beverage 10-Q, filed Nov 6, 2026
- Filed
- CIK
- 0000865752
- Accession no.
- 0001104659-26-123503
Summary
Monster Beverage reported third-quarter net sales of $2.56 billion, up 16.7% from a year earlier, and net income of $568.4 million, or $0.29 per diluted share, driven by higher worldwide demand for its Monster Energy brand energy drinks. Sales outside the United States rose 28.1% to $1.20 billion, and the company launched products including FLRT Apple Bottoms Up, Java Monster Dubai Chocolate and Monster Energy Vanilla Shot.
Key points
- Net sales rose 16.7% to $2.56 billion for the quarter ended September 30, 2026, from $2.20 billion a year earlier.
- Net income was $568.4 million, or $0.29 per diluted share, versus $524.5 million, or $0.27, a year earlier.
- Sales to customers outside the United States were $1.20 billion, up 28.1% and about 47% of net sales.
- Coca-Cola Europacific Partners accounted for roughly 17% of net sales and Coca-Cola Consolidated about 9%.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT’S DISCUSSION Overview We develop, market, sell and distribute energy drink beverages and concentrates for energy drink beverages, primarily under the following brand names: ● Monster Energy® ● Full Throttle® ● Monster Energy Ultra® ● Burn® ● Rehab Monster® ● Mother® ● Monster Energy® Nitro ● Nalu® ● Java Monster® ● Ultra Energy® ● Monster Killer Brew® ● Play® and Power Play® (stylized) ● Punch Monster® ● Relentless® ● Juice Monster® ● BPM® ● Reign Total Body Fuel® ● BU® ● Reign Storm® ● Samurai® ● StormTM ● Live+® ● Bang Energy® ● Predator® ● FLRTTM ● Fury® ● NOS® We also develop, market, sell and distribute craft beers, FMBs and hard seltzers under a number of…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.